GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: EBL-3599 is from a series of antibacterial compounds that target UDP-2,3-diacylglucosamine hydrolase (LpxH), an essential enzyme in the lipopolysaccharide synthesis pathway, that is conserved in the majority of Gram-negative bacteria but absent in human [1]. EBL-3599 is a derivative of JEDI-1444 and was identified as part of a programme to develop LpxH inhibitors with activity against efflux-proficient Gram-negative bacteria.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 5-[(3-aminopropylamino)methyl]-N-[4-[4-(4-cyano-6-methylpyrimidin-2-yl)piperazin-1-yl]sulfonylphenyl]-2-[methyl(methylsulfonyl)amino]benzamide |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
EBL-3599 |
| Other databases | |
| CAS Registry No. | 2851907-53-2 (source: Scifinder) |
| PubChem CID | 175806742 |
| Search Google for chemical match using the InChIKey | JHQIDWIWOVDFPG-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | JHQIDWIWOVDFPG |
| UniChem Compound Search for chemical match using the InChIKey | JHQIDWIWOVDFPG-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | JHQIDWIWOVDFPG-UHFFFAOYSA-N |